CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Kyverna taps ElevateBio to secure commercial supply of autoimmune CAR-T therapy

PartnershipPositive
AI Analysis

Summary

Kyverna has secured ElevateBio as the primary commercial supply partner for its autologous CAR-T cell therapy for autoimmune indications, supporting anticipated U.S. and global launches.

Importance:6/10
Sentiment:
0.50
partnershipCAR-Tautoimmunemanufacturingcommercial supply
Related Companies

Read the original article

Published by BioSpace on July 29, 2026 1:37 PM

Read Original